TH 1020 |
|
カタログ番号GC50374
|
TH 1020はToll様の受容体5(TLR5)/フラジェリン複合体の拮抗剤であり、IC50値は0.85μMである。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1841460-82-9
Sample solution is provided at 25 µL, 10mM.
TH 1020はToll様の受容体5(TLR5)/フラジェリン複合体の拮抗剤であり、IC50値は0.85μMである[1]。TH 1020はフラジェリン誘発のTLR5のシグナル伝達を阻害できるが、TLR2、TLR3、TLR4、TLR7とTLR8に対しては無効である[2]。TH 1020は、TLR5二量体の間の分子インターフェースと結合することで、下流シグナル伝達を阻害し、機能性四量体複合体の機能を抑制する[3]。TH 1020は、CD8+ T細胞で、TLR5シグナル伝達を阻害できる[4]。
体外で、腸管毒素原性大腸菌(ETEC)C83901株に感染したIPEC-J2細胞をTH 1020 (1.5μM)で2時間事前処理した結果、細胞内IL-17Cの分泌を完全に阻害した[5]。TH 1020 (0.75, 1.5μM)で一次末梢血単核細胞(PBMC)を処理した結果、フラジェリンと高移動性グループのタンパク質B1(HMGB1)が誘発した一酸化窒素(NO)の産生を著しく減らした[6]。
体内で、卵巣癌モデルマウスにTH 1020 (100μg)を4日間腹腔内注射した結果、腫瘍微小環境で、CCR2+ Ly6C+細胞の数と腫瘍浸潤マクロファージの総数を著しく減らした[7]。
References:
[1] Patra M C, Choi S. Recent progress in the development of Toll-like receptor (TLR) antagonists[J]. Expert opinion on therapeutic patents, 2016, 26(6): 719-730.
[2] Yan L, Liang J, Yao C, et al. Pyrimidine triazole thioether derivatives as Toll‐like receptor 5 (TLR5)/flagellin complex inhibitors[J]. ChemMedChem, 2016, 11(8): 822-826.
[3] Leifer C A, Medvedev A E. Molecular mechanisms of regulation of Toll-like receptor signaling[J]. Journal of Leucocyte Biology, 2016, 100(5): 927-941.
[4] Kang X, Liu C, Ding Y, et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells[J]. Gut, 2023, 72(11): 2112-2122.
[5] Luo Y, Xu J, Zhang C, et al. Toll-like receptor 5-mediated IL-17C expression in intestinal epithelial cells enhances epithelial host defense against F4+ ETEC infection[J]. Veterinary research, 2019, 50(1): 48.
[6] Das N, Dewan V, Grace P M, et al. HMGB1 activates proinflammatory signaling via TLR5 leading to allodynia[J]. Cell reports, 2016, 17(4): 1128-1140.
[7] Kolli S H, McGinty M T, Putelo A M, et al. Ovarian Cancer Drives TLR5-Dependent Expansion of Myeloid Progenitors Through Systemic Dissemination of Ligands[J]. bioRxiv, 2025: 2025.06. 10.658497.
| 細胞実験[1]: | |
細胞株 | IPEC-J2単層 |
準備方法 | まず、IPEC-J2単層を0.5μMのTH 1020 (0.5μM)、0.5μMのオリゴデオキシリボヌクレオチド(ODN) 2088または等量の溶媒DMSOとTEまたはPBSで2時間事前培養した。次に、単層に、MOI 100で、C83901 (腸管毒素原性大腸菌(ETEC)参照株)を1時間接種し、洗浄し、更に23時間インキュベートした。細胞培養上清で、IL-17Cサイトカインの産生をELISAで分析した。 |
反応条件 | 0.5μM;2時間 |
アプリケーション | C83901感染のIPEC-J2細胞で、TH 1020はIL-17Cの分泌をほぼ完全に阻害した。 |
References: | |
| Cas No. | 1841460-82-9 | SDF | |
| Canonical SMILES | N1(C(SC2=C3SC4=NC=CC=C4C3=NC=N2)=NN=C1C5=CC=NC=C5)CC6=CC=CC=C6 | ||
| Formula | C23H15N7S2 | M.Wt | 453.54 |
| 溶解度 | Chloroform: 1 mg/ml | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.2049 mL | 11.0244 mL | 22.0488 mL |
| 5 mM | 441 μL | 2.2049 mL | 4.4098 mL |
| 10 mM | 220.5 μL | 1.1024 mL | 2.2049 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.50% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)